SevenBridge Financial Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $631K | Sell |
7,587
-616
| -8% | -$59K | 0.1% | 138 |
|
|
2025
Q4 | $826K | Sell |
8,203
-1,909
| -19% | -$185K | 0.13% | 126 |
|
|
2025
Q3 | $969K | Sell |
10,112
-2,832
| -22% | -$260K | 0.16% | 117 |
|
|
2025
Q2 | $1.19M | Sell |
12,944
-1,991
| -13% | -$169K | 0.21% | 113 |
|
|
2025
Q1 | $1.28M | Sell |
14,935
-3,085
| -17% | -$276K | 0.25% | 109 |
|
|
2024
Q4 | $1.64M | Sell |
18,020
-5,119
| -22% | -$443K | 0.31% | 86 |
|
|
2024
Q3 | $2.04M | Sell |
23,139
-60
| -0.3% | -$5.05K | 0.39% | 70 |
|
|
2024
Q2 | $1.87M | Sell |
23,199
-296
| -1% | -$24.3K | 0.41% | 68 |
|
|
2024
Q1 | $1.92M | Buy |
23,495
+2,042
| +10% | +$174K | 0.43% | 65 |
|
|
2023
Q4 | $1.77M | Sell |
21,453
-328
| -2% | -$25K | 0.42% | 70 |
|
|
2023
Q3 | $1.71M | Buy |
21,781
+500
| +2% | +$41.9K | 0.44% | 68 |
|
|
2023
Q2 | $1.87M | Buy |
21,281
+1,525
| +8% | +$131K | 0.48% | 63 |
|
|
2023
Q1 | $1.59M | Buy |
19,756
+2,128
| +12% | +$173K | 0.44% | 65 |
|
|
2022
Q4 | $1.37M | Buy |
17,628
+977
| +6% | +$79.2K | 0.4% | 66 |
|
|
2022
Q3 | $1.34M | Buy |
16,651
+4,751
| +40% | +$427K | 0.46% | 58 |
|
|
2022
Q2 | $1.07M | Buy |
11,900
+708
| +6% | +$71.7K | 0.43% | 63 |
|
|
2022
Q1 | $1.24M | Buy |
11,192
+5,968
| +114% | +$631K | 0.44% | 61 |
|
|
2021
Q4 | $540K | Buy |
5,224
+1,183
| +29% | +$137K | 0.16% | 108 |
|
|
2021
Q3 | $507K | Sell |
4,041
-1
| -0% | -$129 | 0.17% | 105 |
|
|
2021
Q2 | $502K | Buy |
4,042
+237
| +6% | +$29.8K | 0.16% | 106 |
|
|
2021
Q1 | $449K | Sell |
3,805
-45
| -1% | -$5.27K | 0.16% | 110 |
|
|
2020
Q4 | $451K | Buy |
3,850
+735
| +24% | +$80.9K | 0.18% | 102 |
|
|
2020
Q3 | $324K | Sell |
3,115
-55
| -2% | -$5.52K | 0.15% | 107 |
|
|
2020
Q2 | $291K | Sell |
3,170
-77
| -2% | -$7.38K | 0.14% | 106 |
|
|
2020
Q1 | $293K | Buy |
3,247
+96
| +3% | +$10.2K | 0.17% | 99 |
|
|
2019
Q4 | $357K | Hold |
3,151
| – | – | 0.09% | 115 |
|
|
2019
Q3 | $342K | Hold |
3,151
| – | – | 0.18% | 100 |
|
|
2019
Q2 | $307K | Sell |
3,151
-375
| -11% | -$34.2K | 0.11% | 117 |
|
|
2019
Q1 | $321K | Buy |
3,526
+199
| +6% | +$17.8K | 0.12% | 104 |
|
|
2018
Q4 | $303K | Sell |
3,327
-39
| -1% | -$3.64K | 0.19% | 88 |
|
|
2018
Q3 | $331K | Buy |
3,366
+410
| +14% | +$37.9K | 0.18% | 97 |
|
|
2018
Q2 | $253K | Buy |
2,956
+1,119
| +61% | +$93.5K | 0.14% | 119 |
|
|
2018
Q1 | $147K | Sell |
1,837
-110
| -6% | -$9.07K | 0.08% | 153 |
|
|
2017
Q4 | $157K | Sell |
1,947
-250
| -11% | -$20K | 0.09% | 153 |
|
|
2017
Q3 | $171K | Buy |
2,197
+950
| +76% | +$78.9K | 0.1% | 145 |
|
|
2017
Q2 | $111K | Hold |
1,247
| – | – | 0.07% | 179 |
|
|
2017
Q1 | $100K | Sell |
1,247
-936
| -43% | -$73.1K | 0.07% | 175 |
|
|
2016
Q4 | $182K | Hold |
2,183
| – | – | 0.13% | 138 |
|
|
2016
Q3 | $182K | Sell |
2,183
-144
| -6% | -$12.5K | 0.13% | 138 |
|
|
2016
Q2 | $202K | Buy |
+2,327
| New | +$188K | 0.14% | 134 |
|
Other funds holding MDT
VCM
VPM
SevenBridge Financial Group's MDT Position: Q1 2026 in Review
SevenBridge Financial Group reduced its Medtronic (MDT) stake by 7.5% in Q1 2026, selling an estimated $59K and leaving 7,587 shares worth $631K. The position accounts for 0.1% of the portfolio, ranked #138.
SevenBridge Financial Group first reported a position in MDT in Q2 2016 and has held it in 40 quarters since. The position peaked at $2.04M in Q3 2024. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- SevenBridge Financial Group held 7,587 shares of Medtronic worth $631K as of Q1 2026.
- SevenBridge Financial Group sold 616 Medtronic shares in Q1 2026, an estimated $59K.
- Medtronic made up 0.1% of SevenBridge Financial Group's portfolio in Q1 2026, its #138 holding.
- SevenBridge Financial Group first reported a position in Medtronic in Q2 2016 and has held it in 40 quarters since.
- SevenBridge Financial Group's Medtronic position peaked at $2.04M in Q3 2024.
- 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on SevenBridge Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.